Xeris Biopharma Holdings, Inc.

Q2 2023 13F Holders

Symbol
XERS
CUSIP
98422E103
Type
Equity
Class
COM
Num filings
111
Total reported value, excl. options
$147 M
Manager Report Date Value ($000) Shares Option Type